| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |